Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Artificial Intelligence (AI) in Australia GLP-1 Receptor Agonist Market Artificial Intelligence is widely being implemented for enhancing the development and applications of GLP-1 receptor agonists with the ultimate aim of better management of obesity and diabetes
The results were a total of 218 RCTs (339 arms and 77 950 patients) met the inclusion criteria
NAFLD and Liver Inflammation Non-alcoholic fatty liver disease (NAFLD) is an increasingly common hepatic manifestation of metabolic dysfunction
The woman enrolled in a small trial at Penn that involved using NAc-focused electrical stimulation to help ease food noise in the brain
US$ 21.19
US$ 29.72
US$ 28.06
US$ 21.44
US$ 29.81
US$ 20.48
US$ 24.62
